Biosplice Therapeutics has a total of 471 patents globally, out of which 220 have been granted. Of these 471 patents, more than 80% patents are active. Japan is where Biosplice Therapeutics has filed the maximum number of patents, followed by China and Australia. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of Biosplice Therapeutics.
Biosplice Therapeutics was founded in 2008 by Osman Kibar. Biosplice Therapeutics operates as a biotech company. The Company focuses on osteoarthritis and oncology, with early-stage programs in neurology and other areas. Biosplice Therapeutics serves customers in the United States.
Read about some of the most popular patents of Biosplice Therapeutics which have been covered by us in this article and also you can find Biosplice Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Biosplice Therapeutics patent portfolio.
How many patents does the Founder and CEO of Biosplice Therapeutics have?
The Founder Osman Kibar have 91 patents and the CEO Cevdet Samikoglu have 0 patents.
How many patents does Biosplice Therapeutics have?
Biosplice Therapeutics has a total of 471 patents globally. These patents belong to 81 unique patent families. Out of 471 patents, 379 patents are active.
How Many Patents did Biosplice Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Biosplice Therapeutics Applications Filed||Biosplice Therapeutics Patents Granted|
How many Biosplice Therapeutics patents are Alive/Dead?
How Many Patents did Biosplice Therapeutics File in Different Countries?
Countries in which Biosplice Therapeutics Filed Patents
|Hong Kong (S.A.R.)||16|
|United States Of America||4|
|United Arab Emirates||3|
Where are Research Centers of Biosplice Therapeutics Patents Located?
10 Best Biosplice Therapeutics Patents
US20110034441A1 is the most popular patent in the Biosplice Therapeutics portfolio. It has received 144 citations so far from companies like Samumed Llc, Merck Patent Gmbh and Epitherix Llc.
Below is the list of 10 most cited patents of Biosplice Therapeutics:
|Publication Number||Citation Count|
What Percentage of Biosplice Therapeutics US Patent Applications were Granted?
Biosplice Therapeutics (Excluding its subsidiaries) has filed 96 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 85 have been granted leading to a grant rate of 98.8%.
Below are the key stats of Biosplice Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Biosplice Therapeutics?
|Law Firm||Total Applications||Success Rate|
|Fish & Richardson Pc||96||98.84%|
EXCLUSIVE INSIGHTS COMING SOON!